@FierceMedDev: Investors propel St. Jude Medical to new heights over 2013 rebound. Article | Follow @FierceMedDev
@MarkHFierce: So, how many device companies will go for FDA/CMS parallel review now that the pilot program has been extended? More | Follow @MarkHFierce
@MichaelGFierce: Synapse collects state-funded $2.4M for next-gen diaphragm pacing device. Item | Follow @MichaelGFierce
@GalenMoore: ICYMI: Despite tax hike, Medtronic's money still flies to Puerto Rico. Story | Follow @GalenMoore
> China's Mindray Medical ($MR) has re-elected two board members, the medical device giant disclosed. Item
> The FDA has slapped Class II status on a recall of thousands of components used in Intuitive Surgical's ($ISRG) da Vinci surgical robot. Story
> Covidien ($COV) plans to release its fiscal 2014 first-quarter results on Jan. 24, 2014. Item
> Medicina, a U.K. device outfit that makes syringes, tubes and pumps for nutrition delivery, pulled in $9.8 million in new funding. Story
> Blaze Bioscience is launching a clinical trial of a new injectable imaging agent for various kinds of skin cancer. Item
Biotech News
@FierceBiotech: Alimera, pSivida skyrocket as they give the thrice-rejected Iluvien another go. More | Follow @FierceBiotech
@JohnCFierce: Another day, another positive PhIII study for AMG 145 (PCSK9). Release | Follow @JohnCFierce
@DamianFierce: GSK and Theravance score another FDA approval with Anoro, a novel COPD combo therapy. News | Follow @DamianFierce
@EmilyMFierce: BRAIN Initiative announces 6 funding opportunities for biomedical researchers. More from FierceBiotech Research | Follow @EmilyMFierce
> Alimera, pSivida skyrocket as they give the thrice-rejected Iluvien another go. Article
> Vertex's Kalydeco flunks a Phase III for cystic fibrosis. Story
> AstraZeneca will pay up to $4.1B for Bristol's share of their diabetes pact. More
> Bayer bags Algeta's cancer drug portfolio for $2.9B. News
Pharma News
@FiercePharma: South Africa's top business daily accuses its state pension fund of protectionism vs. a $1.2B deal with Chile's CFR Pharma. More from Reuters | Follow @FiercePharma
@EricPFierce: AstraZeneca gets former Amylin plant & Bristol-Myers Ohio plant in breakup of diabetes venture. Story from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: As GSK hails its FDA nod for Anoro, a Novartis Advair knockoff prepares for its close-up. Story | Follow @CarlyHFierce
> With a sweetened $2.9B bid, Bayer nabs its Xofigo partner, Algeta. Report
> Bristol-Myers bails out of 'Diabetes Inc.' in $4.1B sell-out to AstraZeneca. Story
> GlaxoSmithKline scores FDA nod for blockbuster COPD hopeful Anoro Ellipta. News
> Raised eyebrows at patient charity spotlight copay assistance debate. More
Pharma Manufacturing News
> Hacked off: Congress members, PhRMA urge an outside audit of the FDA data breach. Story
> Regeneron will invest $300M, hire 300 in its revamp of a Dell plant in Ireland. More
> The FDA and EU members will share some inspection duties. News
> AstraZeneca will take over 2 U.S. plants in its $4.1B diabetes drug transfer. Report
> CEO Nakayama says Daiichi Sankyo is helping Ranbaxy deal with the FDA's concerns. Article
> FDA puts veterinary drugs from banned Wockhardt plants on a leash. Item
Vaccines News
> Schulman leaves Pfizer weeks before start date of new top vaccine job. More
> CDC: Vaccines prevented 6M cases of flu, 79,000 hospitalizations last year. News
> Moderate alcohol consumption acts as vaccine adjuvant in monkeys. Article
> Physician failings raise doubts about the potency of U.K. vaccines. Story
> Agenus stock jumps on Phase II brain cancer vaccine data. Piece
> California calls for unapproved Bexsero to stop its meningitis outbreak. Item